Daniel Rauh
TU Dortmund University · 387 works · 13,527 citations · h-index 57
Top works
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
- Highly enantioselective synthesis and cellular evaluation of spirooxindoles inspired by natural products
- Structure-guided development of affinity probes for tyrosine kinases using chemical genetics
- Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer
- Small-molecule inhibition of APT1 affects Ras localization and signaling
- An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules
- Interactive exploration of chemical space with Scaffold Hunter
- ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
- Natural-product-derived fragments for fragment-based ligand discovery
- Identification of Thiazolidinones Spiro‐Fused to Indolin‐2‐ones as Potent and Selective Inhibitors of the Mycobacterium tuberculosis Protein Tyrosine Phosphatase B
- Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors
- Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc
- Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
- A framework for identification of actionable cancer genome dependencies in small cell lung cancer
- Bioactivity-guided mapping and navigation of chemical space
- A new screening assay for allosteric inhibitors of cSrc